The point of departure of our analysis was the relative weakness
of European SME's vis-a-vis American and Japanese companies. With
a growth in the figures for numbers of SME's in European
biotechnology and stagnation in the figures of U.S.A. it seems
that a bridging numerically between Europe and U.S.A. can be
observed. However this by no means implies that the technological
capability gap is disappering. A first cause for the American
strength can be found in the availability of venture capital in
U.S.A..
Place of Publication | Grenoble |
---|
Publisher | INRA/SERD |
---|
Number of pages | 90 |
---|
Publication status | Published - 1996 |
---|